Tlie Senior Leaders are responsible for tlie overall planning and operations of the programs and activities of the Vanderbilt-lngram Cancer Center (VICC). The Senior Leadership is comprised of the Director, Deputy Director and nine Associate Directors and has undergone transition during the current project period. As part of a planned succession following the successful 2003 competing renewal, Harold Moses, M.D., stepped down and Raymond DuBois, M.D., was named Director in in January 2005. Two years later he he left to become Provost and Executive Vice President of Academic Affairs at M.D. Anderson Cancer Center. Jennifer Pietenpol, Ph.D., then Associate Director for Basic Research, was asked to serve as interim director during a national search. In January 2008, she was selected as Director based on scientific accomplishments, leadership skills and administrative experience. Scott Hiebert, Ph.D., previously leader of the Signal Transduction and Cell Proliferation Research Program, was named Associate Director for Basic Science Research Programs in 2008 overseeing the basic science research programs and implementing the strategic plan for these programs. Also in 2008, William Blot, Ph.D., was named Associate Director for Cancer Prevention, Control and Population-Based Research. He provides senior leadership to the two coleaders of the Cancer Epidemiology, Prevention and Control Research Program. Four additional Associate Director positions have been added. Dr. Elizabeth Williams was recruited in 2005 as Associate Director for Minority Affairs with primary responsibility for health promotion, education, access to care, clinical trials and behavioral interventions for minority populations. Bettina Beech, Dr.P.H., was named in 2006 as Associate Director for Health Disparities Research, responsible for the promotion of health disparities research. In 2008, Beth Price, M.B.A., was named Associate Director for Administration and CEO and in 2009, Dr. Yu Shyr was named Associate Director for Quantitative Sciences Integration with oversight for integrating quantitative science throughout the center and facilitating VICC member access to complex genomic tools and analysis of high-dimensional data sets. Senior Leadership otherwise remains unchanged with David Johnson, M.D., as Deputy Director;Daniel Beauchamp, M.D., as Associate Director for Clinical Research Programs;Mark Magnuson, Ph.D., as Associate Director for Shared Resources;Ann Richmond, Ph.D., as Associate Director for Research Education;and Ms. Susan Mills as Associate Director for CCSG Administration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733552
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$314,679
Indirect Cost
$89,303
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255

Showing the most recent 10 out of 2462 publications